Page 46 - 南京医科大学学报自然科学版
P. 46

第41卷第6期
               ·824 ·                            南 京    医 科 大 学 学         报                        2021年6月


               A            PBS                 c⁃Met⁃lgG1         c⁃Met⁃lgG1⁃rAGAP  B    400
                                                                                         ( 个 )  300


                 IOSE386                                                                 侵袭细胞数目  200
                                                                                          100

                                                                                           0
                                                                                               PBS c⁃Met⁃lgG1  rAGAP
                                                                                                    c⁃Met⁃lgG1⁃

               A                                                                     C
                                                                                                    **
                                                                                          400
                                                                                         ( 个 )  300  *
                  HO8910                                                                  200          *
                                                                                         侵袭细胞数目  100


                                                                                           0
                                                                                                    c⁃Met⁃lgG1⁃
                                                                                               PBS
                                                                                                c⁃Met⁃lgG1  rAGAP
                 A:Transwell 实验检测结果(×200);B:不同处理对 IOSE386 细胞侵袭能力的影响;C:不同处理对 HO8910 细胞侵袭能力的影响。两组比
              较,P < 0.01,P < 0.001(n=3)。
                       **
                *
                         图10 Transwell侵袭实验检测c⁃Met⁃IgG1和c⁃Met⁃IgG1⁃rAGAP对卵巢癌细胞侵袭的抑制作用
              Figure 10 The inhibition of the invasion of IgG1⁃AGAP and Met⁃IgG1 to ovarian cancer cells by Transwell migration assay

              肿瘤靶向药物,将细胞毒性分子与肿瘤细胞靶向抗                                 body⁃drug conjugate optimization for targeted cancer ther⁃
              体结合在一起,从而将化疗药物选择性递送至肿瘤                                 apeutics[J]. Biomol Ther(Seoul),2015,23(6):493-509
              细胞,增加了细胞毒性药物的治疗范围且减少药物                            [6] FAN G,ZHANG S,GAO Y,et al. HGF⁃independent regu⁃
              不良反应,目前已经是临床上肿瘤治疗研究的一个                                 lation of Met and GAB1 by nonreceptor tyrosine kinase
                                                                     FER potentiates metastasis in ovarian cancer[J]. Genes
              重要方向     [20] ,本研究中抗体融合蛋白 c⁃Met⁃IgG1⁃
                                                                     Dev,2016,30(13):1542-1557
              rAGAP 既保留了 c⁃Met⁃IgG1 的靶向特性,又将蝎毒
                                                                [7] SHAO Z,PAN H,TU S,et al. HGF/c⁃Met axis:the ad⁃
              肽集中在肿瘤部位发挥细胞毒性作用,会减轻药物
                                                                     vanced development in digestive system cancer[J]. Front
              对其他正常组织的损伤。综上所述,未来该抗体可                                 Cell Dev Biol,2020,8:801
              能会在 c⁃Met 阳性肿瘤的疾病诊断、靶向治疗中发                        [8] WU C C,WENG C S,HSU Y T,et al. Antitumor effects of
              挥重要价值。                                                 BMS⁃777607 on ovarian cancer cells with constitutively
                                                                     activated c⁃MET[J]. Taiwan J Obstet Gynecol,2019,58
             [参考文献]
                                                                    (1):145-152
             [1] TORRE L A,TRABERT B,DESANTIS C E,et al. Ovari⁃  [9] DEYING W,FENG G,SHUMEI L,et al. CAF ⁃ derived
                   an cancer statistics,2018[J]. CA Cancer J Clin,2018,68  HGF promotes cell proliferation and drug resistance by up
                  (4):284-296                                        ⁃regulating the c⁃Met/PI3K/Akt and GRP78 signalling in
             [2] LI J,ZHI X,SHEN X,et al. Depletion of UBE2C reduces  ovarian cancer cells[J]. Biosci Rep,2017,37(2):
                   ovarian cancer malignancy and reverses cisplatin resis⁃  BSR20160470
                   tance via downregulating CDK1[J]. Biochem Biophys  [10] LIU S,ZHENG Y,VOLPI D,et al. Toward operative in vi⁃
                   Res Commun,2020,523(2):434-440                    vo fluorescence imaging of the c⁃Met proto⁃oncogene for
             [3] LI R,GONG L,LI P,et al. MicroRNA⁃128/homeobox B8    personalization of therapy in ovarian cancer[J]. Cancer,
                   axis regulates ovarian cancer cell progression[J]. Basic  2015,121(2):202-213
                   Clin Pharmacol Toxicol,2019,125(6):499-507   [11] 肖桂元. 蝎毒抗肿瘤研究进展[J]. 中国肿瘤生物治疗
             [4] YAGHOUBI S,KARIMI M H,LOTFINIA M,et al. Poten⁃      杂志,1999(2):161-163
                   tial drugs used in the antibody⁃drug conjugate(ADC)ar⁃  [12] 葛贤秀,曹  鹏,卢悟广,等. 重组东亚钳蝎镇痛抗肿瘤
                   chitecture for cancer therapy[J]. J Cell Physiol,2020,235  肽抑制人胆管癌细胞生长作用及其机制研究[J]. 医学
                  (1):31-64                                          研究生学报,2013,26(4):343-347
             [5] KIM E G,KIM K M. Strategies and advancement in anti⁃  [13] 金思思,吴金明,申苏建. 东亚钳蝎镇痛抗肿瘤肽体外
   41   42   43   44   45   46   47   48   49   50   51